{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:06:21Z","timestamp":1790877981320,"version":"4.1.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","award":["131984"],"award-info":[{"award-number":["131984"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.euf.2026.05.003","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T19:53:04Z","timestamp":1779565984000},"page":"633-635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Prostate Resection Versus Minimally Invasive Surgery Evaluation Trial (PREMISE Trial) and Why We Need It"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1961-1405","authenticated-orcid":false,"given":"Toby","family":"Page","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Drake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2026.05.003_b0005","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/bju.15286","article-title":"The rising worldwide impact of benign prostatic hyperplasia","volume":"127","author":"Launer","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2026.05.003_b0010","unstructured":"NHS England. HES data. https:\/\/digital.nhs.uk\/data-and-information\/data-tools-and-services."},{"key":"10.1016\/j.euf.2026.05.003_b0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/bju.15154","article-title":"The role of novel minimally invasive treatments for lower urinary tract symptoms associated with benign prostatic hyperplasia","volume":"126","author":"Madersbacher","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2026.05.003_b0020","doi-asserted-by":"crossref","unstructured":"Loufopoulos I, Papaefstathiou E, Cornu JN, Gratzke C, Apostolidis A. Prognostic Factors of Persistent overactive bladder\/Storage Symptoms following Deobstruction Surgery for benign prostatic Enlargement in Males: a Systematic Review. Eur Urol Focus. In press. https:\/\/doi.org\/10.1016\/j.euf.2025.12.005.","DOI":"10.1016\/j.euf.2025.12.005"},{"key":"10.1016\/j.euf.2026.05.003_b0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/bju.16713","article-title":"Surgery for benign prostate enlargement in England: 10-year retrospective study of 155\u2009874 patients","volume":"136","author":"Page","year":"2025","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2026.05.003_b0030","doi-asserted-by":"crossref","unstructured":"Carletti F, Tamborino F, Turcan A, et al. Five-year retreatment and medication restart rates following benign prostate hyperplasia treatments: A nationwide real-world analysis using epic cosmos. Eur Urol Focus. In press. https:\/\/doi.org\/10.1016\/j.euf.2026.01.003.","DOI":"10.1016\/j.euf.2026.01.003"},{"key":"10.1016\/j.euf.2026.05.003_b0035","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/bju.13714","article-title":"Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study","volume":"119","author":"Gratzke","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2026.05.003_b0040","unstructured":"Hashim H, Herrmann TRW, Malde S, et al. EAU guidelines on non-neurogenic Male lower urinary tract symptoms (LUTS). In: Cornu JN, chair. Guidelines associates; 2026: M. Baboudjian, M. Creta, M.B. Duran, L. Moris, N. Pyrgidis Guidelines Office: N. Schouten. https:\/\/d56bochluxqnz.cloudfront.net\/documents\/full-guideline\/EAU-Guidelines-on-Non-Neurogenic-Male-LUTS-2024.pdf."},{"key":"10.1016\/j.euf.2026.05.003_b0045","unstructured":"Study details | NCT04757116 | Post-market study to assess iTind safety in comparison to UroLift. Clinicaltrials.gov."},{"key":"10.1016\/j.euf.2026.05.003_b0050","unstructured":"Study details | NCT06820606 | Comparing Rezum and urolift. Clinicaltrials.gov."},{"key":"10.1016\/j.euf.2026.05.003_b0055","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.eururo.2015.07.054","article-title":"A multicenter randomized noninferiority trial comparing GreenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-yr outcomes of the GOLIATH study","volume":"69","author":"Thomas","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2026.05.003_b0060","unstructured":"ISRCTN. ISRCTN50571778: PREMISE: a surgical trial of minimally invasive treatments of prostate obstruction of the bladder. https:\/\/www.isrctn.com\/ISRCTN50571778."}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456926000714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456926000714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:31:27Z","timestamp":1790875887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456926000714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2405456926000714"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2026.05.003","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Prostate Resection Versus Minimally Invasive Surgery Evaluation Trial (PREMISE Trial) and Why We Need It","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2026.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}